Follow
Giulia Mantini
Giulia Mantini
PhD, Amsterdam UMC
Verified email at amsterdamumc.nl
Title
Cited by
Cited by
Year
Role of c-MET inhibitors in overcoming drug resistance in spheroid models of primary human pancreatic cancer and stellate cells
O Firuzi, PP Che, B El Hassouni, M Buijs, S Coppola, M Löhr, N Funel, ...
Cancers 11 (5), 638, 2019
622019
Imidazo [2, 1-b][1, 3, 4] thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells
S Cascioferro, GL Petri, B Parrino, D Carbone, N Funel, C Bergonzini, ...
European journal of medicinal chemistry 189, 112088, 2020
602020
Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets
TYS Le Large, G Mantini, LL Meijer, TV Pham, N Funel, NCT van Grieken, ...
JCI insight 5 (15), 2020
392020
Detection and localization of early-and late-stage cancers using platelet RNA
S GJG, M Arkani, E Post, M Antunes-Ferreira, S D’Ambrosi, DCL Vessies, ...
Cancer Cell 40 (9), 999-1009. e6, 2022
352022
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds
G Li Petri, B El Hassouni, R Sciarrillo, N Funel, G Mantini, ...
British journal of cancer 123 (4), 644-656, 2020
322020
Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma
TYS Le Large, MF Bijlsma, B El Hassouni, G Mantini, T Lagerweij, ...
Journal of Experimental & Clinical Cancer Research 40, 1-12, 2021
312021
Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers
G Mantini, AM Vallés, TYS Le Large, M Capula, N Funel, TV Pham, ...
Cellular oncology 43, 1147-1159, 2020
272020
Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
C Granchi, G Bononi, R Ferrisi, E Gori, G Mantini, S Glasmacher, G Poli, ...
European journal of medicinal chemistry 209, 112857, 2021
262021
“Open Sesame?”: Biomarker status of the human equilibrative nucleoside transporter-1 and molecular mechanisms influencing its expression and activity in the uptake and …
O Randazzo, F Papini, G Mantini, A Gregori, B Parrino, DSK Liu, ...
Cancers 12 (11), 3206, 2020
242020
New avenues in pancreatic cancer: exploiting microRNAs as predictive biomarkers and new approaches to target aberrant metabolism
M Capula, G Mantini, N Funel, E Giovannetti
Expert Review of Clinical Pharmacology 12 (12), 1081-1090, 2019
242019
Computational analysis of phosphoproteomics data in multi‐omics cancer studies
G Mantini, TV Pham, SR Piersma, CR Jimenez
Proteomics 21 (3-4), 1900312, 2021
212021
Omics analysis of educated platelets in cancer and benign disease of the pancreas
G Mantini, LL Meijer, I Glogovitis, SGJG In ‘t Veld, R Paleckyte, M Capula, ...
Cancers 13 (1), 66, 2020
202020
To combine or not combine: drug interactions and tools for their analysis. Reflections from the EORTC-PAMM course on preclinical and early-phase clinical pharmacology
B El Hassouni, G Mantini, GL Petri, M Capula, L Boyd, HNW Weinstein, ...
Anticancer research 39 (7), 3303-3309, 2019
202019
CX-5461 inhibits pancreatic ductal adenocarcinoma cell growth, migration and induces DNA damage
B El Hassouni, G Mantini, B Immordino, GJ Peters, E Giovannetti
Molecules 24 (24), 4445, 2019
192019
Uridine cytidine kinase 2 as a potential biomarker for treatment with RX-3117 in pancreatic cancer
B El Hassouni, J Infante, G Mantini, C Ricci, N Funel, E Giovannetti, ...
Anticancer research 39 (7), 3609-3614, 2019
82019
Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma
A Vallés-Martí, G Mantini, P Manoukian, C Waasdorp, AF Sarasqueta, ...
Cell reports 42 (6), 2023
72023
Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma
IGP Supadmanaba, G Mantini, O Randazzo, M Capula, IB Muller, ...
Epigenetics 17 (4), 381-404, 2022
72022
Prognostic significance of integrin subunit alpha 2 (ITGA2) and role of mechanical cues in resistance to gemcitabine in pancreatic ductal adenocarcinoma (PDAC)
A Gregori, C Bergonzini, M Capula, G Mantini, F Khojasteh-Leylakoohi, ...
Cancers 15 (3), 628, 2023
62023
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells
C Bergonzini, A Gregori, TMS Hagens, VE van der Noord, B van de Water, ...
Journal of Experimental & Clinical Cancer Research 43 (1), 4, 2024
22024
Targeting hypoxic pancreatic cancer cells with glucose conjugated lactate dehydrogenase inhibitor NHI-Glc-2
BE Hassouni, R Sciarrillo, VE Gómez, M Maftouh, G Mantini, CM Vonk, ...
Cancer Research 79 (13_Supplement), 3082-3082, 2019
22019
The system can't perform the operation now. Try again later.
Articles 1–20